Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/IOVS.04-0915PMID 15914619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.

  2004cited by this paper
• Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina

  2004cited by this paper
• Cardioprotective effects of adenosine A1 and A 3 receptor activation during hypoxia in isolated rat cardiac myocytes

  2004cited by this paper
• Intraocular Adenosine Levels in Normal and Ocular-Hypertensive Patients

  2003influential reference
• 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome

  2003cited by this paper
• Recent developments in the field of A2A and A3 adenosine receptor antagonists.

  2003cited by this paper
• Retinal vascular development and oxygen-induced retinopathy: a role for adenosine.

  2003cited by this paper
• Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans.

  2003influential reference
• Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport

  2003cited by this paper
• The fall and rise of active chloride transport: implications for regulation of intraocular pressure.

  2003cited by this paper
• Adenosine receptor signaling and the activation of mitogen-activated protein kinases

  2002cited by this paper
• Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues.

  2002cited by this paper
• Knockout of A3 adenosine receptors reduces mouse intraocular pressure.

  2002influential reference
• Exfoliation syndrome.

  2001cited by this paper
• Exfoliation syndrome.

  2001cited by this paper
• Adenosine, adenosine receptors and myocardial protection: an updated overview.

  2001cited by this paper
• A1‐, A2A‐ and A3‐subtype adenosine receptors modulate intraocular pressure in the mouse

  2001cited by this paper
• Adenosine, oxidative stress and cytoprotection.

  2001influential reference
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cited by this paper
• Adenosine receptor up‐regulation: initiated upon preconditioning but not upheld

  2000cited by this paper
• Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.

  2000cited by this paper
• A3 adenosine receptors regulate Cl-channels of nonpigmented ciliary epithelial cells.

  1999cited by this paper
• A physiological role of the adenosine A3 receptor: sustained cardioprotection.

  1998cited by this paper
• Measurement of adenosine concentration in aqueous and vitreous.

  1998cited by this paper
• A release mechanism for stored ATP in ocular ciliary epithelial cells.

  1998cited by this paper
• Localization of adenosine receptor messenger RNAs in the rat eye.

  1997cited by this paper
• Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells.

  1997cited by this paper
• Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys.

  1997cited by this paper
• Adenosine stimulates Cl- channels of nonpigmented ciliary epithelial cells.

  1997cited by this paper
• Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats.

  1997influential reference
• Adenosine promotes regulation of corneal hydration through cyclic adenosine monophosphate.

  1996cited by this paper
• Involvement of adenosine in retinal ischemia. Studies on the rat.

  1996cited by this paper
• Characterization of ocular hypertension induced by adenosine agonists.

  1996cited by this paper
• Adenosine receptor activation modulates intraocular pressure in rabbits.

  1995cited by this paper
• Effects of adenosine on ocular blood flow.

  1995cited by this paper
• Adenosine acts as an endogenous activator of the cellular antioxidant defense system.

  1994cited by this paper
• Stimulation of A2 adenosine receptors inhibits the ingestion of photoreceptor outer segments by retinal pigment epithelium.

  1994cited by this paper
• Immunoprecipitation of A1 adenosine receptor-GTP-binding protein complexes in ciliary epithelial cells.

  1994cited by this paper
• Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome.

  1994cited by this paper
• Purinergic receptors in ocular ciliary epithelial cells.

  1993cited by this paper
• Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart.

  1993cited by this paper
• Microcirculatory Responses to Adenosine in the Newborn Pig Retina

  1993cited by this paper
• Evidence for the Action of Endogenous Adenosine in the Rabbit Retina: Modulation of the Light‐Evoked Release of Acetylcholine

  1992cited by this paper
• Adenosine Receptors

  1990cited by this paper
• Intravitreous injection of adenosine or its agonists causes breakdown of the blood-retinal barrier.

  1989cited by this paper
• Expression of Na,K‐ATPase alpha subunit isoforms in the human ciliary body and cultured ciliary epithelial cells

  1989cited by this paper
• Adenosine and its agonists cause retinal vasodilation and hemorrhages. Implications for ischemic retinopathies.

  1989cited by this paper
• The Potential Role of Adenosine in Regulating Blood Flow in the Eye

  1988cited by this paper
• Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion.

  1988cited by this paper
• Dynamics of Aqueous Humorin the Syndrome of Exfoliatio with Glaucoma

  1982cited by this paper
• Dynamics of aqueous humor in the syndrome of exfoliation with glaucoma.

  1982cited by this paper

• Susceptibility to pseudoexfoliation linked to intronic variant rs4926246 in CACNA1A: Evidence from an Indian population study.

  2025cites this paper
• Current understanding of genetics and epigenetics in pseudoexfoliation syndrome and glaucoma.

  2023cites this paper
• Species dependence of A3 adenosine receptor pharmacology and function

  2022cites this paper
• Adenosine A3 receptor activated in H2O2 oxidative stress of primary open-angle glaucoma

  2021cites this paper
• Adenosine: The common target between cancer immunotherapy and glaucoma in the eye.

  2021cites this paper
• Aqueous Humor and the Dynamics of Its Flow: Mechanisms and Routes of Aqueous Humor Drainage

  2021cites this paper
• Adenosine receptors as promising targets for the management of ocular diseases

  2021cites this paper
• Discovery of 2-aminoimidazole and 2-amino imidazolyl-thiazoles as non-xanthine human adenosine A3 receptor antagonists: SAR and molecular modeling studies.

  2018cites this paper
• Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice

  2018cites this paper
• IOP lowering effect of topical trans‐resveratrol involves adenosine receptors and TGF‐&bgr;2 signaling pathways

  2018cites this paper
• Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.

  2017cites this paper
• Topical treatment of glaucoma: established and emerging pharmacology

  2017cites this paper
• Glaucoma Posttranscriptional Regulation of LOXL 1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response

  2017cites this paper
• Ocular Purine Receptors as Drug Targets in the Eye

  2016cites this paper
• The A3 Adenosine Receptor: History and Perspectives

  2015cites this paper
• Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.

  2015cites this paper
• Role of adenosine receptors in resveratrol‐induced intraocular pressure lowering in rats with steroid‐induced ocular hypertension

  2015cites this paper
• Molecular and epidemiological studies on eyes with pseudoexfoliation syndrome

  2015cites this paper
• Purinergic Receptors in Ocular Inflammation

  2014cites this paper
• Genomic and Proteomic Pathophysiology of Pseudoexfoliation Glaucoma

  2014cites this paper
• Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways

  2014cites this paper
• Medical Management of Exfoliative Glaucoma

  2014cites this paper
• Targeting the A3 adenosine receptor for glaucoma treatment (review).

  2013cites this paper
• Adenosine, adenosine receptors and glaucoma: an updated overview.

  2013cites this paper
• Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations

  2012cites this paper
• Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation.

  2012cites this paper
• Pharmacological and therapeutic effects of A3 adenosine receptor agonists.

  2012cites this paper
• Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.

  2012cites this paper
• Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands

  2012cites this paper
• New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.

  2011cites this paper
• Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101.

  2011cites this paper
• Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.

  2011cites this paper
• Human brain endothelial cells are responsive to adenosine receptor activation

  2011cites this paper
• A3 Adenosine Receptor Antagonists: History and Future Perspectives

  2010cites this paper
• Oxidativer Stress beim Pseudoexfoliationsglaukom

  2010cites this paper
• The Activities of Paraoxonase, Xanthine Oxidase, Adenosine Deaminase and the Level of Nitrite in Pseudoexfoliation Syndrome

  2009cites this paper
• The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease.

  2009cites this paper
• Significant Association of ADORA3 Genetic Polymorphisms with Aspirin-Intolerant Urticaria in a Korean Population

  2009cites this paper
• Genetic pathways of Lyst and exfoliation syndrome

  2009cites this paper
• Caracterización de la entrada de Ca2+ "capacitativa" en células trabeculares

  2009cites this paper
• A3 adenosine receptor: pharmacology and role in disease.

  2009cites this paper
• Molecular genetics of primary open angle glaucoma and exfoliation syndrome

  2009cites this paper
• Mechanisms of Glaucoma

  2009cites this paper
• The molecular pathophysiology of pseudoexfoliation glaucoma

  2008cites this paper
• The A3 adenosine receptor: an enigmatic player in cell biology.

  2008cites this paper
• Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery.

  2008cites this paper
• Chapter 1 Formation of the Aqueous Humor

  2008cites this paper
• Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists.

  2008cites this paper
• Mechanisms of Aqueous Humor Formation

  2008cites this paper
• Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

  2007cites this paper
• Genome-wide scan of exfoliation syndrome.

  2007cites this paper
• Adenosine Inhibition of Lipopolysaccharide-Induced Interleukin-6 Secretion by the Osteoblastic Cell Line MG-63

  2007influential citation
• Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.

  2007cites this paper
• Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.

  2007cites this paper
• [Advanced glycation end products and pseudoexfoliation--correlation between clinical outcome and histological findings].

  2006cites this paper
• Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue.

  2006cites this paper
• Ocular and systemic pseudoexfoliation syndrome.

  2006cites this paper
• Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.

  2006cites this paper
• Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression

  2006cites this paper
• Swelling‐activated chloride channels in aqueous humour formation: on the one side and the other

  2006cites this paper
• Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells.

  2005cites this paper
• The Cross-Species A3 Adenosine-Receptor Antagonist MRS 1292 Inhibits Adenosine-Triggered Human Nonpigmented Ciliary Epithelial Cell Fluid Release and Reduces Mouse Intraocular Pressure

  2005cites this paper
• Differential gene expression in pseudoexfoliation syndrome.

  2005cites this paper
• Basis of Chloride Transport in Ciliary Epithelium

  2004cites this paper